The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations

<p>Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative condition that affects corticospinal and spinal motor neurons and leads to death within 30 months of symptom onset in half of all cases. It remains incurable and treatment is supportive. The genetic and molecular understanding of AL...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Scaber, J
Άλλοι συγγραφείς: Talbot, K
Μορφή: Thesis
Γλώσσα:English
Έκδοση: 2017
_version_ 1826295699437780992
author Scaber, J
author2 Talbot, K
author_facet Talbot, K
Scaber, J
author_sort Scaber, J
collection OXFORD
description <p>Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative condition that affects corticospinal and spinal motor neurons and leads to death within 30 months of symptom onset in half of all cases. It remains incurable and treatment is supportive. The genetic and molecular understanding of ALS has gone through a rapid expansion in recent years, notably with the discoveries of TDP-43, a heterogeneous ribonucleoprotein as a major component of neuronal inclusions in ALS, as well as the discovery of the <em>C9orf72</em> hexanucleotide expansion as the most common genetic cause of this disease.</p> <p>This first part of this thesis addresses the question of which of the various pathological hallmarks of the <em>C9orf72</em> Hexanucleotide Repeat Expansion (HRE) in autopsy material correlates best with the clinical presentation. The main finding is that TDP-43 distribution, rather than C9orf72 RNA foci or dipeptide aggregation in the brain, corresponds best with the areas relevant to the clinical subtype of ALS-FTD. Subsequently the role of TDP-43 was investigated in induced pluripotent stem cell derived motor neurons, and no evidence of the hallmarks of TDP-43 dysfunction, were seen in this model of the disease. No mislocalisation is found on immunofluorescence, and biochemical analysis shows no differences in insoluble species between the patient and control cell lines. In the final section, RNA sequencing was used to study the transcriptome of a BAC transgenic mouse carrying a human M337V transgene expressed at low levels, to identify early presymptomatic differences in gene expression. Interestingly, no changes were found in genes known to be associated with ALS through mutations, and the constitutive nuclear functions of TDP-43 in the regulation of splicing was maintained, prior to the emergence of a clinical phenotype in the mouse. This favours a gain of function mechanism for TDP-43 mutations in ALS.</p>
first_indexed 2024-03-07T04:05:04Z
format Thesis
id oxford-uuid:c5dd8dcf-c3e0-4ff7-ba9d-bfd3cb9914e8
institution University of Oxford
language English
last_indexed 2024-03-07T04:05:04Z
publishDate 2017
record_format dspace
spelling oxford-uuid:c5dd8dcf-c3e0-4ff7-ba9d-bfd3cb9914e82022-03-27T06:34:07ZThe pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutationsThesishttp://purl.org/coar/resource_type/c_db06uuid:c5dd8dcf-c3e0-4ff7-ba9d-bfd3cb9914e8EnglishORA Deposit2017Scaber, JTalbot, K<p>Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative condition that affects corticospinal and spinal motor neurons and leads to death within 30 months of symptom onset in half of all cases. It remains incurable and treatment is supportive. The genetic and molecular understanding of ALS has gone through a rapid expansion in recent years, notably with the discoveries of TDP-43, a heterogeneous ribonucleoprotein as a major component of neuronal inclusions in ALS, as well as the discovery of the <em>C9orf72</em> hexanucleotide expansion as the most common genetic cause of this disease.</p> <p>This first part of this thesis addresses the question of which of the various pathological hallmarks of the <em>C9orf72</em> Hexanucleotide Repeat Expansion (HRE) in autopsy material correlates best with the clinical presentation. The main finding is that TDP-43 distribution, rather than C9orf72 RNA foci or dipeptide aggregation in the brain, corresponds best with the areas relevant to the clinical subtype of ALS-FTD. Subsequently the role of TDP-43 was investigated in induced pluripotent stem cell derived motor neurons, and no evidence of the hallmarks of TDP-43 dysfunction, were seen in this model of the disease. No mislocalisation is found on immunofluorescence, and biochemical analysis shows no differences in insoluble species between the patient and control cell lines. In the final section, RNA sequencing was used to study the transcriptome of a BAC transgenic mouse carrying a human M337V transgene expressed at low levels, to identify early presymptomatic differences in gene expression. Interestingly, no changes were found in genes known to be associated with ALS through mutations, and the constitutive nuclear functions of TDP-43 in the regulation of splicing was maintained, prior to the emergence of a clinical phenotype in the mouse. This favours a gain of function mechanism for TDP-43 mutations in ALS.</p>
spellingShingle Scaber, J
The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
title The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
title_full The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
title_fullStr The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
title_full_unstemmed The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
title_short The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
title_sort pathophysiological role of tdp 43 in amyotrophic lateral sclerosis due to c9orf72 mutations
work_keys_str_mv AT scaberj thepathophysiologicalroleoftdp43inamyotrophiclateralsclerosisduetoc9orf72mutations
AT scaberj pathophysiologicalroleoftdp43inamyotrophiclateralsclerosisduetoc9orf72mutations